Health insurance; cost-sharing payments for prescription insulin drugs. (HB1403)

Introduced By

Del. Jay Leftwich (R-Chesapeake)


Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law


Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $100 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill was incorporated into HB 66. Read the Bill »


01/28/2020: Incorporated into Another Bill


01/08/2020Prefiled and ordered printed; offered 01/08/20 20100319D
01/08/2020Referred to Committee on Labor and Commerce
01/16/2020Assigned L & C sub: Subcommittee #2
01/22/2020Impact statement from SCC (HB1403)
01/23/2020Subcommittee recommends incorporating (HB66-Carter)
01/28/2020Incorporated by Labor and Commerce (HB66-Carter)